Vir Biotechnology Inc.

NASDAQ: VIR · Real-Time Price · USD
4.51
0.07 (1.58%)
At close: Aug 15, 2025, 3:59 PM
4.49
-0.43%
After-hours: Aug 15, 2025, 07:24 PM EDT

Vir Biotechnology Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-110.96M -120.97M -104.59M -213.72M -138.38M -65.28M -115.97M -163.41M -194.78M -140.96M -101.6M 175.31M -76.49M 518.62M 525.25M 110.43M 61.81M -168.91M
Depreciation & Amortization
9.53M 2.87M 2.89M 2.9M 4.26M 4.52M 4.48M 4.59M 4.75M 5.64M 1.95M 1.68M 1.6M 1.55M 1.52M 1.49M 1.4M 1.4M
Stock-Based Compensation
12.45M 14.06M 15.84M 16.7M 22.16M 23.76M 28.27M 26.94M 30.62M 25.48M 24.86M 24.81M 27.1M 25.3M 24.37M 22.94M 21M 15.47M
Other Working Capital
-27.47M 27.47M -6.32M 16.68M -2.15M -82.48M -280.08M -22.17M -1.54M 2.07M -151.15M -108.73M -2.02M 450.17M 2.48M -84.23M 50.28M 17.45M
Other Non-Cash Items
-5.18M n/a 17.87M 5.09M 67.71M 42.22M 9.11M 172.37M 8.69M -26.67M -4.72M -28.91M 409.25M 698K 52.31M 14.14M -42K 45.97M
Deferred Income Tax
n/a n/a -2.64M 57K -363K n/a -1.06M -166.63M 14.35M n/a -15.19M n/a n/a n/a 15.19M -164.69M -647K 409K
Change in Working Capital
-26.06M 26.06M -17M 17.49M -2.35M -82.15M -32.75M -29.69M -252.88M 10.72M 129.82M -55M 586.63M 3.91M -610.95M -90.12M 56.53M 16.14M
Operating Cash Flow
-120.22M -78.12M -87.64M -171.48M -77.85M -109.39M -107.93M -155.83M -389.25M -125.78M 35.13M 117.9M 960.14M 550.09M 7.7M -105.81M 140.06M -89.53M
Capital Expenditures
-2.54M -1.63M -2.41M -2.36M -666K -1.87M -1.53M -3.71M -9.46M -6.87M -12.6M -18.99M -20.6M -15.84M -13.07M -6.01M -2.08M -667K
Cash Acquisitions
n/a n/a n/a -912K 379K 533K 184.43M 55.24M -239.77M 100K 140.54M 11K -1K 12K -4K 4K n/a n/a
Purchase of Investments
-192.37M -173.69M -160.86M -240.14M -271.4M -562.94M -818.99M -502.91M -309.78M -384.51M -407.21M -728.46M -251.73M -89.56M -364.51M n/a -50.73M -5M
Sales Maturities Of Investments
251.32M 301.86M 301.14M 361.51M 483.29M 592.7M 715.71M 447.67M 549.55M 489.46M 266.67M 84.84M n/a n/a n/a 79.86M 128.18M 93.2M
Other Investing Acitivies
45K 281K 2.87M 505K 212.27M 533K -184.43M -55.24M 239.77M -100K -140.54M -643.61M -251.73M 12K -4K 4K 77.45M 88.2M
Investing Cash Flow
56.46M 126.82M 140.74M 118.6M 211.61M 28.42M -104.81M -58.95M 230.31M 98.08M -153.13M -662.61M -272.33M -105.39M -377.58M 73.86M 75.38M 87.53M
Debt Repayment
n/a n/a n/a -40K -69K -69K n/a n/a -68K -66K -77K -59K -60K -64K -72K -61K -64K -62K
Common Stock Repurchased
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 3.22M n/a n/a n/a 2.3M n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
289K 598K 1.26M 71K 3.01M 221K 1.68M 277K 3.25M 2.41M 2.09M 2.04M 3.14M -713K 5.74M 3.69M 3.59M 2.35M
Financial Cash Flow
2.05M 598K 1.26M 31K 2.94M 152K 1.68M 277K 3.18M 2.34M 2.01M 1.99M 3.08M 27.68M 5.67M 3.63M 3.53M 87.5M
Net Cash Flow
-61.72M 49.3M 54.37M -46.48M 136.76M -80.8M -210.45M -214.51M -155.75M -25.36M -116M -542.72M 690.89M 472.38M -364.22M -28.32M 218.96M 85.51M
Free Cash Flow
-122.76M -79.75M -90.04M -173.84M -78.51M -111.26M -109.46M -159.54M -398.7M -132.65M 22.53M 98.91M 939.54M 534.25M -5.37M -111.82M 137.98M -90.2M